Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01906021 · ClinicalTrials.gov registry record · NA
Study of New Software Used During Ablations
A NA study of Liver Cancer and Hepatic Cancer, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT01906021: Completed NA study of Liver Cancer and Hepatic Cancer, sponsored by National Institutes of Health Clinical Center (CC).
NCT01906021 is a NA study of Liver Cancer and Hepatic Cancer that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 13 participants, below the 448-participant average among 78 other Liver Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01906021, a NA study of Liver Cancer and Hepatic Cancer, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Ablation is a procedure that heats tumor tissue to a high temperature to destroy it. Doctors perform this procedure by putting a probe in the tumor. This delivers heat to the site. Currently, doctors tell what area is heated by using the probe s manufacturer estimates. These estimates are imprecise. Doctors insert small needles to measure the temperature around the area being heated. Doctors also perform scans of the area, but these cannot show which tissue has been heated and which has not. Right now, only contrast scans can show that. But researchers have developed software that uses images from routine scans to create a temperature map. They want to test the software to see if doctors can monitor the procedure without using more needles and without contrast scans. Objectives: \- To test software that might help doctors perform ablations better in the future. Eligibility: \- People over 18 years of age already scheduled to have an ablation. Design: * Participants will be screened with a medical history. * Participants will visit the clinic for their already-scheduled ablation. The doctor will use the study software to analyze the temperature in the area being heated. The software will not come into contact with a participant s body. \- Participants will undergo scans that are necessary for the procedure, but one or two additional scans may be done as part of this study.
Primary Outcome
Bayesian median estimate will be used.
Conditions Studied
Interventions
- PROCEDURE CT/CBCT thermometry method
- PROCEDURE Ablation Probe
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-09-23 |
| Est. Completion | 2020-12-08 |
| Phase | NA |
What the finished NCT01906021 record still lists
NCT01906021 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 448-participant average among 78 other Liver Cancer trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Liver Cancer appearing as the primary indexed condition, and to 2 interventions - of which CT/CBCT thermometry method is the first listed.
NCT01906021 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01906021 about?
NCT01906021 is a clinical study titled "Study of New Software Used During Ablations". Background: \- Ablation is a procedure that heats tumor tissue to a high temperature to destroy it. Doctors perform this procedure by putting a probe in the tumor. This delivers heat to the site. Currently, doctors tell what area is heated by using the probe s manufacturer estimates. These estimate...
What is the current status of trial NCT01906021?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2013-09-23. Estimated completion is 2020-12-08.
What conditions does trial NCT01906021 study?
This clinical trial studies the following conditions: Liver Cancer, Hepatic Cancer, Hepatic Neoplasms, Neoplasms, Liver.
What interventions are being tested in trial NCT01906021?
The interventions under investigation include: CT/CBCT thermometry method (PROCEDURE), Ablation Probe (PROCEDURE).
Who is sponsoring clinical trial NCT01906021?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01906021 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01906021's enrollment target sits among peer trials
13 73rd of 78 higher than 6 of 78 other Liver Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
-
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
RECRUITING · NA
-
Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI